MAI Capital Management - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 71 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
MAI Capital Management ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$860,888
-9.9%
369,480
-8.0%
0.01%
-7.1%
Q2 2023$955,560
+19.8%
401,496
-7.4%
0.01%
+7.7%
Q1 2023$797,944
-13.0%
433,665
-10.1%
0.01%
-13.3%
Q4 2022$917,039
+19.4%
482,652
+34.4%
0.02%
+7.1%
Q3 2022$768,000
-25.7%
359,110
-1.7%
0.01%
-30.0%
Q2 2022$1,034,000365,4070.02%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,283,966$15,166,0001.40%
Sio Capital Management, LLC 591,870$3,930,0000.98%
TFG Asset Management GP Ltd 2,500,000$16,600,0000.90%
Ikarian Capital, LLC 1,356,048$9,004,0000.73%
SABBY MANAGEMENT, LLC 400,050$2,656,0000.37%
Nantahala Capital Management 1,793,500$11,909,0000.34%
Regency Capital Management Inc.\DE 57,000$378,0000.29%
Eversept Partners, LP 473,074$3,141,2110.21%
MYDA Advisors LLC 85,000$564,0000.14%
Henry James International Management Inc. 54,047$359,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders